#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Rosai-Dorfman syndrome Hypoparathyroidism Primary immunodeficiency syndrome Ventricular fibrillation Thrombocytopenia Neovascular age-related macular degeneration Glomerulonephritis chronic Ewing's sarcoma metastatic Small for dates baby Polycythaemia vera Congenital absence of bile ducts Cutaneous lupus erythematosus Epilepsy Von Willebrand's disease More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Trials in Disease Ewing’s sarcoma recurrent – Diagnostics Angelman’s syndrome – Life with Disease Pelizaeus-Merzbacher disease – Trials in Disease Angiosarcoma – Life with Disease Cytokine release syndrome – Treatment Biotinidase deficiency – Treatment Cholangitis sclerosing – Life with Disease Loeys-Dietz syndrome – Diagnostics Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avutometinib Metamizole 64Cu-Dota-Ae105 For-6219 Pegipanermin TRIGLYCERIDES MEDIUM CHAIN Deutivacaftor Tuparstobart Aficamten Cetirizine Dihydrochloride Jk06 ACT-1004-1239 Amphotericin B Quercus Robur Pollen Extract Levodropropizine Atomoxetine Hydrochloride Bleomycin Lenacapavir Vemircopan Linagliptin More therapies…

    Learn about Your Condition

    Vomiting Essential hypertension Hepatitis alcoholic Undifferentiated sarcoma Cutaneous sarcoidosis Peripheral artery thrombosis Dent's disease Hyperparathyroidism secondary Hypersomnia Lymphocytic leukaemia Double hit lymphoma Peritoneal abscess Rosai-Dorfman syndrome Hypochondroplasia Yellow fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal cell carcinoma

  • Study on the Safety and Effects of Volrustomig and Axitinib for Patients with Advanced Kidney Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Volrustomig
    • Lenvatinib
    France Spain

  • Study of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Palbociclib
    • Belzutifan
    France Germany Italy Poland Spain Sweden

  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Metastatic malignant melanoma
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Alectinib
    • Alectinib Hydrochloride
    • Cobimetinib
    Belgium Czechia France Germany Greece Hungary +5

  • Study of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Vibostolimab
    • Favezelimab
    • Quavonlimab
    France Hungary The Netherlands Poland Spain

  • Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Renal cell carcinoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Lbl-007
    • Surzebiclimab
    • Tislelizumab
    France Italy Poland Spain

  • Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    • Sodium Chloride
    Czechia Finland France Germany Ireland Italy +3
Previous Page
1 … 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!